Evaluation of the Response to a Single Dose of Menactra in Children Aged 5 to 8 Years Who Had Previously Received Two Doses of Quadrivalent (A, C, Y, W 135) Meningococcal Polysaccharide Vaccine Before Age 2 Years in Saudi Arabia.

Trial Profile

Evaluation of the Response to a Single Dose of Menactra in Children Aged 5 to 8 Years Who Had Previously Received Two Doses of Quadrivalent (A, C, Y, W 135) Meningococcal Polysaccharide Vaccine Before Age 2 Years in Saudi Arabia.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Apr 2014

At a glance

  • Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
  • Indications Meningococcal infections
  • Focus Pharmacodynamics; Registrational
  • Sponsors sanofi pasteur
  • Most Recent Events

    • 17 Jul 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
    • 17 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Jul 2009 Actual patient number (238) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top